Skip to main content
Professional Technical IVT

oncotype score

Pronunciation: ON-ko-type

A numerical recurrence score derived from a multigene expression assay used to guide treatment decisions in breast cancer.

Full Definition

The Oncotype Score is a proprietary recurrence score ranging from 0-100 that quantifies the likelihood of distant recurrence in hormone receptor-positive, HER2-negative breast cancer. The score is calculated from the expression levels of 21 genes in tumor tissue and helps oncologists determine whether chemotherapy will benefit the patient in addition to hormone therapy. Lower scores typically indicate lower recurrence risk and may support omitting chemotherapy, while higher scores suggest greater benefit from chemotherapy.

Usage

Usage note: Always capitalize 'Oncotype' as it is a proprietary test name. The score is typically written without units.

In Context

  • "The patient's Oncotype Score of 15 supported the decision to proceed with hormone therapy alone." — Treatment planning report
  • "Oncotype scoring has become standard practice for intermediate-risk breast cancer patients." — Clinical guideline

Also known as

Oncotype DX score 21-gene recurrence score

Don't confuse with

OncotypeDX test gene expression profile

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON